Literature DB >> 92393

The chemotherapy of pulmonary tuberculosis: a review.

W Fox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92393     DOI: 10.1378/chest.76.6_supplement.785

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  10 in total

Review 1.  The chemical biology of new drugs in the development for tuberculosis.

Authors:  Clifton E Barry; John S Blanchard
Journal:  Curr Opin Chem Biol       Date:  2010-05-07       Impact factor: 8.822

2.  Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey.

Authors:  D E Kopanoff; D E Snider; M Johnson
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

3.  Current concepts in the treatment of tuberculosis.

Authors:  I B Tager
Journal:  West J Med       Date:  1987-04

4.  Chemotherapeutic agents in pulmonary tuberculosis with special reference to isoniazid-ethambutol continuation therapy.

Authors:  A W Lees
Journal:  Ir J Med Sci       Date:  1985-05       Impact factor: 1.568

5.  Tuberculosis in patients having dialysis.

Authors:  D A Mitchison; G A Ellard
Journal:  Br Med J       Date:  1980-05-10

6.  Evaluation of rifalazil in long-term treatment regimens for tuberculosis in mice.

Authors:  C M Shoen; S E Chase; M S DeStefano; T S Harpster; A J Chmielewski; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.

Authors:  Helen McIlleron; Roxana Rustomjee; Mahnaz Vahedi; Thuli Mthiyane; Paolo Denti; Catherine Connolly; Wasima Rida; Alexander Pym; Peter J Smith; Philip C Onyebujoh
Journal:  Antimicrob Agents Chemother       Date:  2012-03-12       Impact factor: 5.191

8.  Toxic ocular effects of ethambutol.

Authors:  L M Kahana
Journal:  CMAJ       Date:  1987-08-01       Impact factor: 8.262

9.  'The last dying speech and confession of Bacillus Tuberculosis, Esq., late of Belfast'.

Authors: 
Journal:  Ulster Med J       Date:  1989

Review 10.  How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery.

Authors:  Amala Bhagwat; Aditi Deshpande; Tanya Parish
Journal:  Front Cell Infect Microbiol       Date:  2022-09-09       Impact factor: 6.073

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.